Palisade Bio, Inc.
PALI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6,425 | $3,263 | $3,265 | $9,600 |
| - Cash | $5,227 | $5,417 | $7,230 | $9,821 |
| + Debt | $211 | $24 | $58 | $169 |
| Enterprise Value | $1,409 | -$2,130 | -$3,907 | -$52 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,862 | -$2,781 | -$2,228 | -$3,382 |
| % Margin | – | – | – | – |
| Net Income | -$2,868 | -$2,784 | -$2,230 | -$3,344 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.38 | -0.58 | -0.46 | -0.39 |
| % Growth | 34.5% | -26.1% | -17.9% | – |
| Operating Cash Flow | -$3,553 | -$1,817 | -$2,333 | -$2,381 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3,553 | -$1,817 | -$2,333 | -$2,381 |